A Preview Of Ironwood Pharmaceuticals's Earnings
Portfolio Pulse from Benzinga Insights
Ironwood Pharmaceuticals (NASDAQ:IRWD) is scheduled to release its quarterly earnings report on February 15, 2024. Analysts predict an EPS of $0.21. The company's past earnings performance shows mixed results with both misses and beats in previous quarters. Shares are currently trading at $15.2, reflecting a 37.49% increase over the last 52 weeks. Investors are keenly awaiting the report and guidance for future growth.
February 14, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ironwood Pharmaceuticals is anticipated to report an EPS of $0.21 for the upcoming quarter. Historical performance shows variability in meeting EPS estimates. Shares have risen 37.49% over the past year, indicating positive investor sentiment.
Given the anticipation of the earnings report and the historical stock price increase following earnings announcements, IRWD's stock is likely to experience positive short-term movement, especially if the company beats the EPS estimate and provides favorable future guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100